Top 23 Entyvio Manufacturers for Effective Treatment

Are you navigating the complex world of Entyvio manufacturing? With so many options out there, it can feel overwhelming to find the right supplier for your needs. But choosing the best manufacturer is crucial—not just for quality, but for reliability and cost-effectiveness too. The right partner can ensure that you receive top-notch products that meet stringent standards, giving you peace of mind and a competitive edge.

In this article, we’ll compare the top 30 Entyvio manufacturers, helping you make an informed choice. Ready to discover which factories stand out from the crowd? Dive in and find the perfect fit for your business!

Top 23 Entyvio Manufacturer Manufacturers

Entyvio – Biologic Treatment for Ulcerative Colitis and Crohn’s Disease

Domain: entyvio.com

Registered: 2011 ( 14 years )

Introduction: ENTYVIO (vedolizumab) is a biologic medication used to treat moderate to severe ulcerative colitis and Crohn’s disease in adults when other treatments have not been effective or tolerated.

Entyvio – Gut-Focused Biologic Treatments

Domain: entyviohcp.com

Registered: 2013 ( 12 years )

Introduction: ENTYVIO® (vedolizumab) is a gut-focused biologic medication indicated for adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD). It is available in two forms: intravenous (IV) administration and a subcutaneous pen.

Takeda – Autoimmune Disease Treatments

Domain: takeda.com

Registered: 1997 ( 28 years )

Introduction: Entyvio (vedolizumab) is a medication approved for the treatment of certain autoimmune diseases.

Medicadepot – Entyvio for Ulcerative Colitis and Crohn’s

Domain: medicadepot.com

Registered: 2007 ( 18 years )

Introduction: Entyvio is a medication used for the treatment of ulcerative colitis and Crohn’s disease.

Pharmacy Times – Gastrointestinal Health Solutions

Domain: pharmacytimes.com

Registered: 1997 ( 28 years )

Introduction: Entyvio is a medication developed by Takeda Pharmaceuticals for the treatment of ulcerative colitis and Crohn’s disease.

Clinical Trials Arena – Entyvio for Ulcerative Colitis & Crohn’s

Domain: clinicaltrialsarena.com

Registered: 2009 ( 16 years )

Introduction: Entyvio is a medication used for the treatment of Ulcerative Colitis and Crohn’s disease in the US.

Drugs.com – Entyvio for Ulcerative Colitis & Crohn’s Disease

Domain: drugs.com

Registered: 1998 ( 27 years )

Introduction: Entyvio is a medication used to treat adults with moderate to severe ulcerative colitis and Crohn’s disease.

Rxpharmacycoupons – Entyvio Medication Savings Program

Domain: rxpharmacycoupons.com

Registered: 2011 ( 14 years )

Introduction: Entyvio is a medication offered by Takeda for eligible patients, allowing them to pay as little as $5 per dose through the EntyvioConnect program.

GuidelineCentral – Integrin Receptor Antagonist Solutions

Domain: guidelinecentral.com

Registered: 2007 ( 18 years )

Introduction: Vedolizumab, marketed as Entyvio by Takeda Pharmaceuticals, is an integrin receptor antagonist indicated for the treatment of moderately to severely active ulcerative colitis and Crohn’s disease in adults.

Wemanufacturerdrugcoupons – Entyvio Medication Solutions

Domain: wemanufacturerdrugcoupons.com

Registered: 2022 ( 3 years )

Introduction: Entyvio is a medication used in adults with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD).

Vivoinfusion – Entyvio Treatment for Ulcerative Colitis

Domain: vivoinfusion.com

Registered: 2022 ( 3 years )

Introduction: Entyvio is a medication used for the treatment of ulcerative colitis and Crohn’s disease, focusing on patients who have not responded to other therapies.

On – Inflammatory Bowel Disease Treatment Solutions

Domain: on.rxcoverage.ca

Registered: 2021 ( 4 years )

Introduction: Vedolizumab (Brand: Entyvio) is used for the treatment of inflammatory bowel diseases such as fistulising Crohn’s disease, luminal Crohn’s disease, and ulcerative colitis.

Ncbi – Inflammatory Bowel Disease Treatment Solutions

Domain: ncbi.nlm.nih.gov

Registered: 1997 ( 28 years )

Introduction: Entyvio™ (vedolizumab) is a medication used for the treatment of inflammatory bowel disease, specifically Crohn’s disease and ulcerative colitis.

Prnewswire – Pharmaceutical News and Updates

Domain: prnewswire.com

Registered: 1995 ( 30 years )

Introduction: Entyvio is a medication developed by Takeda for the treatment of ulcerative colitis and Crohn’s disease.

PrescriptionGiant – Prescription Savings Program

Domain: prescriptiongiant.com

Registered: 2005 ( 20 years )

Introduction: PrescriptionGiant offers a free prescription savings program that can save users up to 75% on their prescriptions, including a specific offer for Entyvio where eligible patients can pay as little as $5 per dose through the EntyvioConnect program.

Ema – Autoimmune Disease Treatment Solutions

Domain: ema.europa.eu

Registration year: Not available

Introduction: Entyvio is a medication used for the treatment of certain autoimmune diseases, specifically Ulcerative Colitis and Crohn’s Disease.

Tinygrab – Biologic Treatments for Ulcerative Colitis

Domain: tinygrab.com

Registered: 2008 ( 17 years )

Introduction: Entyvio (vedolizumab) is a biologic drug used to treat moderate to severe ulcerative colitis and Crohn’s disease.

Buyandbill – Immunology Drug Solutions

Domain: buyandbill.com

Registered: 2011 ( 14 years )

Introduction: ENTYVIO is an Immunology drug manufactured by Takeda, administered intravenously, and indicated for the treatment of moderate to severe Crohn’s Disease and Ulcerative Colitis.

Pharmaceutical Technology – Takeda’s Entyvio Solutions

Domain: pharmaceutical-technology.com

Registered: 2000 ( 25 years )

Introduction: Takeda’s Entyvio is a medication approved by the US FDA for the treatment of ulcerative colitis and Crohn’s disease.

Dev – IBD Treatment Solutions

Domain: dev.vivoinfusion.com

Registered: 2022 ( 3 years )

Introduction: Entyvio® (vedolizumab) is a biologic medication used to treat inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). It is an integrin receptor antagonist that specifically targets the gut, reducing inflammation without suppressing the entire immune system.

Star Tribune – Pharmaceutical Manufacturing Solutions

Domain: startribune.com

Registered: 1994 ( 31 years )

Introduction: The company plans to make the drug Entyvio at its new plant in Brooklyn Park.

Medicine – Ulcerative Colitis & Crohn’s Disease Treatment

Domain: medicine.com

Registered: 1997 ( 28 years )

Introduction: Entyvio is a prescription medicine used in adults for the treatment of moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease.

GNH India – Vedolizumab Injection Solutions

Domain: gnhindia.com

Registered: 2004 ( 21 years )

Introduction: Order Vedolizumab (Entyvio) 300 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION online from GNH India.

Category Information

Entyvio, known generically as vedolizumab, is a biologic medication primarily used to treat autoimmune conditions such as ulcerative colitis and Crohn’s disease. It belongs to a category of drugs called integrin inhibitors, which work by targeting specific proteins involved in the inflammatory process. By inhibiting the migration of immune cells to the gut, Entyvio helps to reduce inflammation and promote healing in patients suffering from these chronic conditions.

The manufacturer of Entyvio, Takeda Pharmaceuticals, plays a significant role in the development and distribution of innovative therapies for gastrointestinal diseases. The significance of this category lies in its potential to improve the quality of life for patients with debilitating autoimmune disorders, offering them a more effective treatment option compared to traditional therapies. As research continues, medications like Entyvio represent advancements in precision medicine, targeting specific pathways to mitigate disease symptoms and enhance patient outcomes.

Application Information

Entyvio, manufactured by Takeda Pharmaceutical Company, is primarily used in the treatment of inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s disease. One of the key application areas is gastroenterology, where it serves as a biologic therapy for patients who have not responded to conventional treatments. By targeting specific pathways in the immune system, Entyvio helps reduce inflammation and manage symptoms effectively. Another significant application area is chronic disease management.

Patients with IBD often require long-term treatment plans, and Entyvio provides a maintenance therapy option that can improve quality of life and minimize flare-ups. Additionally, it is utilized in clinical research settings to better understand the mechanisms of IBD and develop further therapeutic strategies. The product’s role in patient support programs also helps ensure adherence to treatment and provides educational resources for both patients and healthcare providers.

Production Process Information

Entyvio (vedolizumab) is a medication used to treat certain autoimmune diseases, and its production involves several key steps. First, the research and development stage focuses on understanding the disease and creating the drug, which includes extensive laboratory testing and clinical trials to ensure safety and efficacy. Once the drug is approved, the manufacturing process begins. This includes sourcing raw materials, such as antibodies, and using biotechnological methods to produce the drug in large quantities.

Quality control is crucial at this stage to ensure that each batch meets safety standards. Finally, the packaging and distribution phase ensures that Entyvio reaches healthcare providers and patients. Throughout this process, regulatory compliance and patient safety are top priorities, ensuring that the medication is effective and safe for those who need it.

Related Video

Frequently Asked Questions (FAQs)

What should I consider when looking for Entyvio manufacturers?
When searching for Entyvio manufacturers, it’s important to consider several factors. First, ensure that the manufacturer is compliant with regulatory standards and has the necessary certifications, such as GMP (Good Manufacturing Practices). Look for their experience in producing biopharmaceuticals, particularly monoclonal antibodies. Additionally, assess their production capacity, quality control processes, and ability to provide reliable delivery timelines. Finally, consider their reputation in the industry by checking reviews or seeking recommendations from other businesses.

How can I verify the credibility of a potential Entyvio manufacturer?
To verify the credibility of a potential manufacturer, start by checking their certifications and licenses. You can also request references from other clients who have worked with them. Conducting a site visit can provide valuable insights into their operations and quality control measures. Furthermore, look for any industry awards or recognitions they may have received. Online platforms and industry forums can also be useful for gathering feedback and reviews about their reliability and quality.

What are the typical costs associated with partnering with an Entyvio manufacturer?
The costs of partnering with an Entyvio manufacturer can vary widely based on several factors, including the scale of production, the complexity of the manufacturing process, and the specific requirements of your project. Generally, you should consider costs for raw materials, production, quality control testing, and packaging. It’s also wise to factor in potential costs for regulatory compliance and any additional services, such as logistics and distribution. Requesting quotes from multiple manufacturers can help you compare and find the best fit for your budget.

How do I ensure the quality of Entyvio produced by a manufacturer?
To ensure the quality of Entyvio produced by a manufacturer, start by reviewing their quality assurance processes. Ask about their testing protocols, including stability and potency testing, as well as their methods for handling deviations or recalls. Request documentation of their quality control measures and any third-party audits they have undergone. Establishing a clear communication channel for ongoing quality discussions and regular audits can also help maintain high standards throughout the production process.

What are the benefits of working with a local versus an international Entyvio manufacturer?
Working with a local manufacturer can offer benefits such as easier communication, faster shipping times, and potentially lower transportation costs. You’ll also have the opportunity for more frequent site visits and closer oversight of the manufacturing process. On the other hand, international manufacturers may provide access to advanced technologies, larger production capacities, and potentially lower production costs. Ultimately, the choice depends on your specific needs, budget, and the level of control you wish to maintain over the manufacturing process.

Similar Posts